KEQU - NASDAQ
Kewaunee Scientific Corporation
$39.56
-2.5%Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates through two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, its subidiaries, and a national distributor. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.
At a Glance
Live SnapshotKewaunee Scientific Corporation Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Cash Flow Quality Insight
Asset-light with strong cash conversion: Low capital requirements combined with efficient cash generation creates significant shareholder value through dividends, buybacks, or strategic investments.
Kewaunee Scientific Corporation Cash Flow Statement
KEQU • NASDAQ
| Kewaunee Scientific Corporation Cash Flow Statement | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | Apr 2009 | Apr 2008 | Apr 2007 | Apr 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
11.6M | 18.8M | 1.4M | -6M | -3.6M | -4.6M | 1.7M | 5.4M | 4.6M | 3.9M | 3.6M | 4M | 3.7M | 1.8M | 2.1M | 3.8M | 4.2M | 3.1M | 1.5M | 193K | |
4.8M | 3.1M | 2.9M | 2.8M | 2.7M | 2.7M | 2.6M | 2.8M | 2.7M | 2.6M | 2.6M | 2.5M | 2.7M | 2.7M | 2.5M | 2.3M | 2.3M | 2M | 2M | 2M | |
-2.2M | -7.1M | 516K | 120K | 1.7M | 1.9M | 202K | 1.1M | 234K | -335K | -513K | 864K | -526K | -1.5M | 223K | -393K | 547K | 940K | 541K | -66K | |
1.4M | 1M | 886K | 729K | 634K | 251K | 197K | 355K | 199K | 192K | 196K | 238K | 239K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
1.2M | 580K | 120K | 92K | 53K | 364K | 65K | 344K | 37K | 74K | 55K | 116K | 34K | 983K | 308K | 163K | -365K | 192K | 136K | 288K | |
(4M) | (6.2M) | (3.2M) | (1M) | (0.0) | (188K) | (2.5M) | (2.9M) | (2.6M) | (2.4M) | (1.9M) | (2.6M) | (1.7M) | (418K) | (1.5M) | (1.3M) | (994K) | (1.1M) | (0.0) | (0.0) | |
-2M | 3.2M | -9.5M | -5.6M | -517K | 3.6M | -2.2M | -6.8M | 3.9M | 871K | -3.7M | 299K | -2.3M | 3.8M | -3.6M | -1.3M | -4.6M | -2.9M | 4.5M | -1.8M | |
14.8M | 19.6M | -3.8M | -7.9M | 912K | 4.2M | 2.5M | 3.2M | 11.7M | 7.3M | 2.3M | 8.1M | 3.8M | 6.9M | 1.3M | 4.5M | 2.1M | 3.4M | 8.7M | -246K | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-2.2M | -4.4M | -4.1M | -1.9M | -2.4M | -2.5M | -4.2M | -3.4M | -2.6M | -2.2M | -2.6M | -2M | -2.4M | -1.4M | -5.2M | -4.2M | -1.5M | -2.5M | -1.7M | -1.9M | |
-28.7M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 193K | 132K | 709K | -1.9M | 323K | 13K | -151K | -9K | -88K | 24K | -108K | 27K | 2.5M | |
-30.9M | -4.4M | -4.1M | -1.9M | -2.4M | -2.5M | -4.2M | -3.2M | -2.5M | -1.5M | -4.5M | -1.7M | -2.4M | -1.6M | -5.3M | -4.3M | -1.5M | -2.7M | -1.7M | (594K) | |
FINANCING ACTIVITIES | ||||||||||||||||||||
-1.6M | -2M | 0.0 | 0.0 | 0.0 | -14K | 0.0 | 0.0 | 0.0 | 479K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -296K | -198K | 681K | 27K | 3K | |
10.8M | -528K | 15.5M | 11M | 2.1M | -6.1M | 4.5M | -624K | -648K | -1.6M | -421K | -2.7M | -55K | -55K | 5.5M | -1.1M | 807K | 702K | -5M | 1.1M | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -1M | -2M | -1.8M | -1.6M | -1.4M | -1.2M | -1.1M | -1M | -1M | -1M | -976K | -1.3M | -708K | -698K | -698K | |
-1.6M | -2M | (0.0) | (0.0) | (0.0) | (0.0) | (36K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -296K | -198K | (0.0) | (0.0) | (0.0) | |
-1.8M | -488K | -575K | 0.0 | -108K | -338K | -87K | -66K | 134K | -963K | 912K | -1.7M | -628K | 0.0 | 34K | -383K | -249K | 0.0 | 0.0 | 0.0 | |
7.4M | -3M | 14.9M | 11M | 2M | -7.5M | 2.3M | -2.5M | -2.1M | -3.4M | -743K | -5.5M | -1.7M | -1.1M | 4.5M | -2.3M | -458K | 675K | -5.7M | 356K | |
CASH FLOW SUMMARY | ||||||||||||||||||||
-67K | -54K | -72K | -75K | 19K | -179K | -413K | -287K | 185K | -211K | -276K | -385K | -94K | -465K | 160K | 243K | -391K | 141K | 0.0 | 0.0 | |
-8.8M | 12.1M | 6.9M | 1.2M | 516K | -5.9M | 198K | -2.8M | 7.3M | 2.2M | -3.2M | 437K | -377K | 3.8M | 680K | -1.8M | -225K | 1.6M | 1.3M | 704K | |
25.9M | 13.8M | 6.9M | 5.7M | 5.2M | 11.2M | 11M | 12.5M | 5.2M | 3M | 6.2M | 5.8M | 6.2M | 2.4M | 1.7M | 3.6M | 3.8M | 2.2M | 929K | 225K | |
17.2M | 25.9M | 13.8M | 6.9M | 5.7M | 5.2M | 11.2M | 9.7M | 12.5M | 5.2M | 3M | 6.2M | 5.8M | 6.2M | 2.4M | 1.7M | 3.6M | 3.8M | 2.2M | 929K | |
12.6M | 15.2M | -7.9M | -9.8M | -1.5M | 1.7M | -1.7M | -212K | 9.1M | 5.1M | -277K | 6M | 1.4M | 5.5M | -4M | 294K | 600K | 845K | 7M | -2.1M |
SEC Filings
KEQU - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | March 13, 2026 | January 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 11, 2026 | March 11, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 25, 2026 | February 25, 2026 | 2026 | |
10-Q 10-Q 2025 Q4 Q4 | December 12, 2025 | October 31, 2025 | 2025 | |
8-K 8-K 2025 N/A | December 10, 2025 | December 10, 2025 | 2025 | |
8-K 8-K 2025 N/A | December 04, 2025 | December 04, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 26, 2025 | November 26, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | September 12, 2025 | July 31, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 11, 2025 | September 10, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 10, 2025 | September 10, 2025 | 2025 |
Related Guides
Continue your KEQU research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.